ロード中...
Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer
BACKGROUND: Proof of the clinical utility of a biomarker is when its use informs a management decision and improves patient outcomes relative to when it is not. OBJECTIVE: To model the clinical benefit of the nuclear-localized AR-V7 test for men with progressing metastatic castration-resistant prost...
保存先:
| 出版年: | Eur Urol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7472426/ https://ncbi.nlm.nih.gov/pubmed/31648903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.08.020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|